Deaths Prompt FDA Crackdown On Colchicine

Law360, New York (February 7, 2008, 12:00 AM EST) -- The U.S. Food and Drug Administration said Wednesday it would be taking enforcement action against companies that market unapproved injectable colchicine in the wake of a slew of deaths related to the drug, which is used to treat gout and other ailments.

The agency said it was bumping up its scrutiny of intravenous colchicine after it became aware of 50 reports of adverse events, including 23 deaths, associated with the use of the drug.

Colchicine is a highly toxic drug that can easily be administered in...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.